Menu

Post image 1
Post image 2
Post image 3
Post image 4
Post image 5
Post image 6
Post image 7
Post image 8
Post image 9
Post image 10
Post image 11
Post image 12
Post image 13
Post image 14
Post image 15
Post image 16
Post image 17
Post image 18
Post image 19
Post image 20
Post image 21
Post image 22
1 / 22
0

Stealth switch in tuberculosis enzyme could open route to drug-resistant treatment

Reading 0:00
15s threshold

Communications Biology (2026). DOI: 10.1038/s42003-026-09821-6, Creative Commons 4.0 license ."> Structure of Mtb ICL2, which forms a homotetramer. Each monomer is indicated by a different colour with one monomer coloured according to the three features present in each monomer. The active site and acetyl-CoA-binding site are also labelled. Credit: Communications Biology (2026). DOI: 10.1038/s42003-026-09821-6, Creative Commons 4.0 license . Recent research published in Communications Biology marks an advance in structural biology by enhancing understanding of protein regulation mechanisms in Mycobacterium tuberculosis (Mtb), a global health threat. The team led by the University of Melbourne combined several advanced techniques at the Australian Synchrotron and the National Deuteration Facility to reveal the hidden allosteric mechanism that activates a key enzyme, ICL2.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.

Read More